An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma

No clinically available biomarkers can predict pathological complete response (pCR) for esophageal squamous cell carcinomas (ESCCs) with neoadjuvant chemoradiotherapy (nCRT). Considering that antitumor immunity status is an important determinant for nCRT, we performed an integrative analysis of immu...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Signal Transduct Target Ther
Main Authors: Zhang, Chaoqi, Zhang, Guochao, Sun, Nan, Zhang, Zhen, Xue, Liyan, Zhang, Zhihui, Yang, Haijun, Luo, Yuejun, Zheng, Xiaoli, Zhang, Yonglei, Yuan, Yufen, Lei, Ruixue, Yang, Zhaoyang, Zheng, Bo, Wang, Le, Che, Yun, Wang, Feng, Wang, Sihui, Gao, Shugeng, Xue, Qi, Zhang, Yi, He, Jie
פורמט: Artigo
שפה:Inglês
יצא לאור: Nature Publishing Group UK 2020
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7471268/
https://ncbi.nlm.nih.gov/pubmed/32883946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41392-020-00221-8
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים